Filtros de búsqueda

Lista de obras de

Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis

artículo científico publicado en 2005

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus

artículo científico publicado en 2005

Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

artículo científico publicado en 2002

Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy

artículo científico publicado en 2004

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

artículo científico publicado en 2002

Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

artículo científico publicado en 2002

Planned Versus Provisional Use of Glycoprotein IIb/IIIa Inhibitors in Smokers Undergoing Percutaneous Coronary Intervention

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Per

Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices

artículo científico publicado en 2004

Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)

artículo científico publicado en 2003

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival

article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology

Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda